These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 30547803)
1. Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1. Gao J; Zhao C; Liu Q; Hou X; Li S; Xing X; Yang C; Luo Y J Exp Clin Cancer Res; 2018 Dec; 37(1):317. PubMed ID: 30547803 [TBL] [Abstract][Full Text] [Related]
2. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression. Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044 [TBL] [Abstract][Full Text] [Related]
3. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex. Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482 [TBL] [Abstract][Full Text] [Related]
4. Cyclin G2 regulates canonical Wnt signalling via interaction with Dapper1 to attenuate tubulointerstitial fibrosis in diabetic nephropathy. Zhao C; Gao J; Li S; Liu Q; Hou X; Xing X; Wang D; Sun M; Wang S; Luo Y J Cell Mol Med; 2020 Mar; 24(5):2749-2760. PubMed ID: 31978940 [TBL] [Abstract][Full Text] [Related]
5. Tumor Suppressor Gene XEDAR Promotes Differentiation and Suppresses Proliferation and Migration of Gastric Cancer Cells Through Upregulating the RELA/LXRα Axis and Deactivating the Wnt/β-Catenin Pathway. Zhang X; Zhang D; Sun X; Li S; Sun Y; Zhai H Cell Transplant; 2021; 30():963689721996346. PubMed ID: 33637015 [TBL] [Abstract][Full Text] [Related]
6. Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis. Higashimori A; Dong Y; Zhang Y; Kang W; Nakatsu G; Ng SSM; Arakawa T; Sung JJY; Chan FKL; Yu J Cancer Res; 2018 Apr; 78(7):1643-1656. PubMed ID: 29374064 [TBL] [Abstract][Full Text] [Related]
7. Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling. Fang F; Zhao WY; Li RK; Yang XM; Li J; Ao JP; Jiang SH; Kong FZ; Tu L; Zhuang C; Qin WX; He P; Zhang WM; Cao H; Zhang ZG Int J Clin Exp Pathol; 2014; 7(10):6447-61. PubMed ID: 25400723 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway. Lu Q; Ma X; Li Y; Song W; Zhang L; Shu Y; Wan B J Cell Biochem; 2019 Mar; 120(3):2897-2907. PubMed ID: 30500980 [TBL] [Abstract][Full Text] [Related]
9. RHBDD1 Promotes the Growth and Stemness Characteristics of Gastric Cancer Cells by Activating Wnt/β-catenin Signaling Pathway. Yang Y; Yuan Y; Xia B Curr Stem Cell Res Ther; 2024; 19(7):1021-1028. PubMed ID: 37861049 [TBL] [Abstract][Full Text] [Related]
10. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma. Chen Q; Zheng PS; Yang WT Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879 [TBL] [Abstract][Full Text] [Related]
11. miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway. Sun GL; Li Z; Wang WZ; Chen Z; Zhang L; Li Q; Wei S; Li BW; Xu JH; Chen L; He ZY; Ying K; Zhang X; Xu H; Zhang DC; Xu ZK J Gastroenterol; 2018 Jun; 53(6):725-739. PubMed ID: 29103082 [TBL] [Abstract][Full Text] [Related]
12. Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling. Bernaudo S; Salem M; Qi X; Zhou W; Zhang C; Yang W; Rosman D; Deng Z; Ye G; Yang BB; Vanderhyden B; Wu Z; Peng C Oncogene; 2016 Sep; 35(36):4816-27. PubMed ID: 26876206 [TBL] [Abstract][Full Text] [Related]
13. PLCD1 Suppressed Cellular Proliferation, Invasion, and Migration via Inhibition of Wnt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma. He X; Meng F; Yu ZJ; Zhu XJ; Qin LY; Wu XR; Liu ZL; Li Y; Zheng YF Dig Dis Sci; 2021 Feb; 66(2):442-451. PubMed ID: 32236884 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of CCAR1, a Coactivator of β-Catenin, Suppresses the Proliferation and Migration of Gastric Cancer Cells. Chang TS; Wei KL; Lu CK; Chen YH; Cheng YT; Tung SY; Wu CS; Chiang MK Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230774 [TBL] [Abstract][Full Text] [Related]
15. Dapper1 is a nucleocytoplasmic shuttling protein that negatively modulates Wnt signaling in the nucleus. Gao X; Wen J; Zhang L; Li X; Ning Y; Meng A; Chen YG J Biol Chem; 2008 Dec; 283(51):35679-88. PubMed ID: 18936100 [TBL] [Abstract][Full Text] [Related]
16. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway. Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806 [TBL] [Abstract][Full Text] [Related]
17. [miR-497 inhibits the growth and metastasis of SGC-7901 human gastric cancer anoikis resistant cells via blocking Wnt/β-catenin signaling pathway]. Yu L; Xu Y; Yang J; Gao L; Li H; Wang Z; Zhang Z; Ling Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jul; 39(7):617-625. PubMed ID: 37403721 [TBL] [Abstract][Full Text] [Related]
18. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination. Liu X; Long Z; Cai H; Yu S; Wu J Cancer Biol Ther; 2020; 21(3):203-212. PubMed ID: 31747856 [No Abstract] [Full Text] [Related]
19. MicroRNA-338 inhibits proliferation, migration, and invasion of gastric cancer cells by the Wnt/β-catenin signaling pathway. Song B; Lin HX; Dong LL; Ma JJ; Jiang ZG Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1290-1296. PubMed ID: 29565486 [TBL] [Abstract][Full Text] [Related]
20. Tumor Inhibitory Effect of Long Non-coding RNA LOC100505817 on Gastric Cancer. Zheng L; Kang L; Cheng Y; Cao J; Liu L; Xu H; Gao L Pathol Oncol Res; 2021; 27():581542. PubMed ID: 34385891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]